Title: Hemostasis in HIV Infected Individuals
Authors: A.Ganesh Raja, T. Usha, V.P.Youmash
DOI: https://dx.doi.org/10.18535/jmscr/v6i8.172
Abstract
With the introduction of cART, HIV infection is slowly evolving into a chronic disease. HIV-related thrombocytopenia is the most common hemostaticdisorder. In addition, there are some abnormalities in the fluid phase of the coagulation cascade which can produce bleeding or thrombosis in the HIV patient. The most common are thrombocytopenia, prolonged prothrombin time, prolonged partially activated thromboplastin time, the production of a lupus anticoagulant and anticardiolipin antibodies, and several abnormalities in the natural-occurring anticoagulants. The thrombotic thrombocytopenic purpura (TTP) recently associated with HIV has a clinical presentation and treatment alternatives that closely resemble those for the classical disease. This study was conducted to know the pattern of these hemostatic abnormalities among PLHA’s. Our study showed most of hemostatic abnormalities occurred with advanced stage of disease which was stastistically significant too. Several thrombotic events were noted in the form of ischemic stroke and DVT, but no clinically significant bleeding manifestations. The knowledge of these hemostatic abnormalities and its early identification in the HIV seropositive patient allows a more rational care of these patients.
Keywords: cART, hemostatic disorder, PLHA, thrombocytopenia, TTP, DVT, lupus anticoagulant
References
- Changes in blood coagulation in HIV infection] Majluf-Cruz A.Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
- Profile of hematological abnormalities in Indian HIV infected individuals-BMC Blood Disorders 2009, 9:5doi:10.1186/1471-2326-9-5
- Journal of Infection Volume 42, Issue 4, July 2001, Pages 251 to 256. Response of Severe HIV-Associated Thrombocytop-enia to Highly Active Antiretroviral Therapy Including Protease Inhibitors
- Ann Biol Clin (Paris) (0) 56: 153-60 [Hemostasis and human immunode-ficiency virus (HIV) infection] West Indian med. j. vol.58 no.5 Mona Nov. 2009
- Correlation of CD4 count with platelet count, Prothrombin time and activated partial thromboplastin time among HIV patients in Benin City,
- Nigeria Neth J Med (2005) 63: 129-36. doi: 10.1177/107602960401000104 CLIN APPL THROMB HEMOST January 2004 vol. 10 no. 1 19-25
- Feffer SE, Fox FL, Orsen MM, et al. Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J. 1995;88:1126-1130.
- Thromboembolism associated with HIV infection-AIDS Read. 2000;10 (8) © 2000 Cliggott Publishing, Division of CMP Healthcare Media
- Attili SVS, Singh VP, Rai M, Varma DV, Gulati AK, Sundar S: Hematological profile of HIV patients in relation to immune status – a hospital-based cohort from Varanasi, North India. Turk J Hematol 2008, 25:13-9.